AI-Driven Oncology Clinical Trial Patient Identification & Recruitment
Total Trials
1
As Lead Sponsor
As Collaborator
0
NCT06462924
Feasibility of Gadolinium Contrast Reduced Brain MRI: the Potential of Deep Learning
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 30, 2024
Completion: Sep 15, 2024
Loading map...